What is the diagnosis and treatment for neutropenic (having an abnormally low number of neutrophils, a type of white blood cell) enterocolitis (inflammation of the small intestine and colon)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Neutropenic enterocolitis should be managed with immediate hospitalization, bowel rest, intravenous fluids, broad-spectrum antibiotics, and pain control, with surgical consultation reserved for complications such as perforation, uncontrolled sepsis, or persistent bleeding, as recommended by the most recent guidelines 1.

Key Management Principles

  • Immediate hospitalization and bowel rest with nothing by mouth
  • Intravenous fluids for hydration
  • Broad-spectrum antibiotics, such as piperacillin-tazobactam 4.5g IV every 6 hours or meropenem 1g IV every 8 hours plus metronidazole 500mg IV every 8 hours, to cover enteric gram-negative organisms, gram-positive organisms, and anaerobes 1
  • Pain control and nasogastric tube decompression as needed
  • Serial abdominal examinations and imaging (CT scans) to monitor disease progression
  • Surgical consultation for potential complications, with indications for surgery including persistent gastrointestinal bleeding, evidence of free intraperitoneal perforation, abscess formation, clinical deterioration, or need to rule out other intra-abdominal processes 1

Antibiotic Therapy

  • Empirical antibiotic approach in neutropenic fever and/or infections, with consideration of antifungal therapy if no clinical improvement is observed 1
  • Antibiotics should be continued for at least 10-14 days or until complete resolution of symptoms

Supportive Care

  • Granulocyte colony-stimulating factors (G-CSF) like filgrastim at 5-10 mcg/kg/day subcutaneously to help recover neutrophil counts
  • Blood transfusions may be necessary due to bloody diarrhea
  • Anticholinergic, antidiarrheal, and opioid agents should be avoided as they may aggravate ileus 1

Prognosis and Mortality

  • Mortality rates range from 30-50%, emphasizing the need for prompt recognition and aggressive treatment
  • Clinical improvement and neutrophil count recovery (ANC >500/mm³) are crucial for a favorable outcome, with diet gradually advanced and antibiotics continued until complete resolution of symptoms 1

From the Research

Definition and Characteristics of Neutropenic Enterocolitis

  • Neutropenic enterocolitis is a life-threatening gastrointestinal (GI) complication of chemotherapy, most often associated with leukemia or lymphoma 2, 3.
  • It is characterized by an inflammatory process involving the colon and/or small bowel, which can result in ischemia, necrosis, bacteremia, hemorrhage, and perforation 4.
  • The classic clinical features include fever and abdominal pain, with presenting signs and symptoms also possibly including nausea, vomiting, and diarrhea 5.

Diagnosis of Neutropenic Enterocolitis

  • The diagnosis is supported by the findings of bowel wall thickening on ultrasonography or CT imaging 4, 3.
  • Neutropenic patients with fever and abdominal symptoms should undergo evaluation of the abdomen for bowel wall thickening of >4 mm, the hallmark of neutropenic enterocolitis 3.
  • Clostridium difficile infection should be ruled out, as well as other etiologies such as graft-versus-host disease 3.

Management of Neutropenic Enterocolitis

  • The management of neutropenic enterocolitis is controversial, with no prospective or high-quality retrospective studies concerning medical or surgical therapies available 2, 4.
  • Most authors recommend initial conservative management with bowel rest, intravenous fluids, total parenteral nutrition, broad-spectrum antibiotics, and normalization of neutrophil counts 2, 4, 3.
  • Surgical intervention is recommended in the setting of obstruction, perforation, persistent gastrointestinal bleeding despite correction of thrombocytopenia and coagulopathy, and clinical deterioration 2, 4, 3.
  • Surgical intervention may be necessary to manage complications such as hemorrhage and perforation and should be delayed, if possible, until recovery from neutropenia 3.

Outcomes and Prognosis

  • The mortality rate for neutropenic enterocolitis is significant, with a reported mortality rate of 31% in medically managed cases and 23% in cases requiring surgical intervention 6.
  • Early recognition and treatment are essential for survival, with rapid identification and timely, aggressive medical and/or surgical intervention being the cornerstones of survival for these patients 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Neutropenic enterocolitis.

Current treatment options in gastroenterology, 2006

Research

Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013

Research

Neutropenic enterocolitis: current issues in diagnosis and management.

Current infectious disease reports, 2007

Research

Neutropenic enterocolitis.

Hematology/oncology clinics of North America, 2010

Research

Neutropenic enterocolitis: A continuing medical and surgical challenge.

North American journal of medical sciences, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.